BP 2007 Annual Report Download - page 120

118
5 Segmental analysis continued
$ million
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2005
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Consolidation
Rest of Rest of adjustment and
By geographical area UK Europe US World eliminations Total
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Sales and other operating revenues
Segment sales and other operating revenues 95,375 72,972 101,190 60,314 – 329,851
Less: sales attributable to Innovene operations (2,610) (8,667) (4,309) (686) – (16,272)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Segment revenues from continuing operations 92,765 64,305 96,881 59,628 – 313,579
Less: sales between areas (38,081) (5,013) (2,362) (16,541) – (61,997)
Less: sales by continuing operations to Innovene (5,599) (4,640) (1,508) (43) – (11,790)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Third party sales of continuing operations 49,085 54,652 93,011 43,044 – 239,792
Equity-accounted earnings (8) 18 86 3,447 – 3,543
Interest and other revenues (533) 152 695 299 – 613
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Total revenues 48,544 54,822 93,792 46,790 – 243,948
Segment results
Profit before interest and tax from continuing operations 1,167 5,206 13,139 13,170 – 32,682
Finance costs and other finance expense (80) (268) (366) (47) – (761)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit before taxation from continuing operations 1,087 4,938 12,773 13,123 – 31,921
Taxation (289) (1,646) (3,983) (3,555) – (9,473)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit for the year from continuing operations 798 3,292 8,790 9,568 – 22,448
Profit (loss) from Innovene operations 234 109 (165) 6 – 184
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit for the year 1,032 3,401 8,625 9,574 – 22,632
Other segment information
Depreciation, depletion and amortization 2,080 932 3,685 2,074 – 8,771
Exploration expense 32 2 425 225 – 684
Impairment losses 53 7 238 61 – 359
Loss on remeasurement to fair value less costs to sell and on
disposal of Innovene operations 24 273 262 32 – 591
Losses on sale of businesses and fixed assets –37 864 –1
Gains on sale of businesses and fixed assets 107 1,017 282 132 – 1,538
09